Company Overview and News
TORONTO/VANCOUVER, BRITISH COLUMBIA – Canada became the first industrialized nation to legalize recreational cannabis on Wednesday, but a lawful buzz will be hard to come by in its biggest cities like Toronto and Vancouver, where stores are not yet open.
ACB SHOP WEED ACBFF CGC
(Reuters) - Constellation Brands Inc’s (STZ.N) Rob Sands is stepping down as CEO, ending an era in which the family-backed alcohol producer became one of the biggest beer brewers in the United States and placed a multi-billion dollar bet on the cannabis industry.
STZ.B WEED STZ CGC
TORONTO/VANCOUVER, Oct 17 (Reuters) - Canada became the first industrialized nation to legalize recreational cannabis on Wednesday, but a lawful buzz will be hard to come by in its biggest cities like Toronto and Vancouver, where stores are not yet open.
ACB SHOP WEED ACBFF CGC
(Reuters) - Corona beer maker Constellation Brands (STZ.N) said on Wednesday its Chief Executive Officer Rob Sands will step down in March and be replaced by the company’s President Bill Newlands.
STZ.B WEED STZ CGC
Constellation Brands Inc., a family-controlled company that transformed itself from a boxed-wine seller to a beverage giant that brews Corona and has bet big on marijuana, is handing the reins to an outsider for the first time.
STZ.B WEED STZ CGC
NEW YORK, NY / ACCESSWIRE / October 17, 2018 / Fresh Harvest Products, Inc. (OTC PINK: FRHV), today is pleased to announce that it will be entering into the cannabis edibles market and cannabis-infused beverage market.
FRHV STZ.B WEED STZ CGC
Shares in most Canadian marijuana companies were lower on Wednesday, a sign that the volatility that has characterized the space as an investment isn't going to go away now that the drug has been made legal for recreational use.
STZ.B APH WEED STZ APHQF CGC
Popular marijuana stocks fell across the board Wednesday, paring extreme gains so far this year, as investors cashed in a bit of their bet as Canada became the largest country to legalize the recreational use of cannabis.
STZ.B ACB WEED ACBFF CRON DTK STZ CGC
Philip Morris International is set to unveil its third quarter of 2018 earnings Thursday, as the industry undergoes radical shifts in product offerings, innovation, and regulatory scrutiny.
STZ.B BUDZ PM WEED BATS 4162 STZ PYX CGC MO
18h investorplace - 2
New Age Beverages (NASDAQ:NBEV) has emerged as a backdoor cannabis play. The Denver-based purveyor of ready-to-drink healthy beverages has seen its stock price spike amid rumors that it would begin to make cannabis-infused drinks.
ABRW WEED KO NBEV CGC TLRY
What a rebound in the stock market! The PowerShares QQQ ETF (NASDAQ:QQQ) surged 2.6%, the Dow Jones jumped almost 500 points and for once, small caps led the rally rather than the decline. That sets up a ton of must-see stock charts and top stock trades for tomorrow.
IBM GE QQQ GEC CGC ADBE BAC GS JPM WEED GNE MS DPZ SNAP
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to TSXV:WEED / Canopy Growth Corporation on message board site Silicon Investor.